PEOPLE - Incyte Genomics makes appointment:
This article was originally published in Clinica
Executive Summary
Incyte Genomics, a developer and marketer of theranostics, has announced the appointments of Paul Friedman as CEO and Robert Stein as president and chief scientific officer. Both Dr Friedman and Dr Stein most recently served DuPont Merck Pharmaceuticals.